Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Pharmaceuticals Secures USD $1.9 Million Sales Contract for SmoothX 2% (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Teleflex Inc TFX

Healthcare Medical Devices
Teleflex Incorporated is a global provider of medical technology products. The Company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The Company has four segments: Americas, EMEA (Europe, the Middle East and Africa), Asia... see more

Recent & Breaking News (NYSE:TFX)

Teleflex Publishes 2021 Global Impact Report

GlobeNewswire July 29, 2022

Teleflex Announces Quarterly Dividend

GlobeNewswire July 28, 2022

Teleflex Reports Second Quarter Financial Results And Full Year Outlook

GlobeNewswire July 28, 2022

Teleflex Announces Pocono Raceway NASCAR Event to Raise Visibility of Enlarged Prostate and the Importance of Regular Health Screenings

GlobeNewswire July 21, 2022

Teleflex Announces Second Quarter 2022 Earnings Conference Call Information

GlobeNewswire July 14, 2022

New Data Reinforce Efficacy of the UroLift® System for the Treatment of Enlarged Prostate

GlobeNewswire July 1, 2022

Teleflex Announces First Patient Enrollment in MANTA Ultra Study

GlobeNewswire June 22, 2022

Teleflex Celebrates June Men's Health Month with Launch of UroLift® Patient Ambassador Program

GlobeNewswire June 1, 2022

Teleflex Hosts 2022 Analyst & Investor Day

GlobeNewswire May 20, 2022

Teleflex Announces Regulatory Clearance for its UroLift® System in China for the Treatment of Benign Prostatic Hyperplasia (BPH)

GlobeNewswire May 19, 2022

Teleflex Announces Health Canada Approval of MANTA® Vascular Closure Device

GlobeNewswire May 18, 2022

3D Systems Announces Establishment of Medical Advisory Board & Appointment of Dr. Stephen K. Klasko as Chair

GlobeNewswire May 16, 2022

Teleflex Announces Full U.S. Commercial Launch of the UroLift® 2 System and UroLift ATC ® Advanced Tissue Control System

GlobeNewswire May 13, 2022

Teleflex to Host Analyst & Investor Day on May 20, 2022

GlobeNewswire May 2, 2022

Teleflex Announces Quarterly Dividend

GlobeNewswire May 2, 2022

Teleflex Reports First Quarter Financial Results And Full Year Outlook

GlobeNewswire April 28, 2022

Teleflex Named to Forbes Best Employers for Diversity 2022 List

GlobeNewswire April 26, 2022

Teleflex to Present at the Bank of America Securities 2022 Healthcare Conference

GlobeNewswire April 26, 2022

Teleflex Announces First Quarter 2022 Earnings Conference Call Information

GlobeNewswire April 14, 2022

Teleflex Announces the Launch of the UroLift® System in Japan for the Treatment of Benign Prostatic Hyperplasia (BPH)

GlobeNewswire April 11, 2022